Matches in Nanopublications for { ?s ?p "[Activation of FOXO1 and 3a and a decreased expression of their target gene Cyclin D1 were also observed after 6 days of in vivo treatment with dasatinib in a CML transgenic mouse model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Activation of FOXO1 and 3a and a decreased expression of their target gene Cyclin D1 were also observed after 6 days of in vivo treatment with dasatinib in a CML transgenic mouse model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of FOXO1 and 3a and a decreased expression of their target gene Cyclin D1 were also observed after 6 days of in vivo treatment with dasatinib in a CML transgenic mouse model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_assertion description "[Activation of FOXO1 and 3a and a decreased expression of their target gene Cyclin D1 were also observed after 6 days of in vivo treatment with dasatinib in a CML transgenic mouse model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_provenance.
- NP1180413.RAn9cV-7ikmLXO8vPybdd8JOUIolFkkhMj5zztNveKOvc130_assertion description "[Activation of FOXO1 and 3a and a decreased expression of their target gene Cyclin D1 were also observed after 6 days of in vivo treatment with dasatinib in a CML transgenic mouse model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1180413.RAn9cV-7ikmLXO8vPybdd8JOUIolFkkhMj5zztNveKOvc130_provenance.